Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration.
Beata UrbanMagdalena SzwabowiczAlina Bakunowicz-ŁazarczykPublished in: Journal of ophthalmology (2020)
Repeated intravitreal injections of 0.5 mg of ranibizumab or 2 mg of aflibercept can influence the morphology of the corneal endothelium but not CCT.